University of New Mexico School of Medicine, Department of Obstetrics and Gynecology, 1 University of New Mexico, Albuquerque, NM, USA.
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Contraception. 2021 Apr;103(4):232-238. doi: 10.1016/j.contraception.2021.01.004. Epub 2021 Jan 14.
OBJECTIVE(S): We estimated the prevalence of requiring specific examinations or tests before providing contraception in a nationwide survey of family planning providers.
We conducted a cross-sectional survey of public-sector health centers and office-based physicians providing family planning services across the United States in 2019 (n = 1395). We estimated the weighted proportion of providers (or their health center or practice) who required blood pressure measurement, pelvic examination (bimanual examination and cervical inspection), Papanicolaou (Pap) smear, clinical breast examination (CBE), and chlamydia and gonorrhea (CT/GC) screening before initiating hormonal or intrauterine contraception (IUC) for healthy women. We performed multivariable regression to identify factors associated with pelvic examination practices aligned with clinical recommendations; these recommendations classify examinations and tests as recommended or unnecessary before initiation of specific contraceptive methods.
The overall response rate was 51%. Most providers required blood pressure measurement before initiating each method. Unnecessary CBE, Pap smears, and CT/GC screening were required by 14% to 33% of providers across methods. Fifty-two to 62% of providers required recommended pelvic examination before IUC placement; however, 16% to 23% of providers required unnecessary pelvic examinations before non-intrauterine hormonal method initiation. Factors associated with recommendation-aligned pelvic examination practices included having a higher proportion of patients using public funding (Medicaid or other assistance) and more recently completing formal clinical training.
Almost half (47%) of providers did not require necessary pelvic examination before placing IUC. Conversely, many providers required unnecessary examinations and tests before contraception initiation for patients.
Most providers required the few recommended examinations and tests for safe contraceptive provision. Reduction of unnecessary examinations and tests may reduce barriers to contraceptive access. There are also opportunities to increase use of recommended examinations, as up to 48% of providers did not require recommended pelvic examination before IUC.
我们通过对美国计划生育服务提供者进行的全国性调查,评估在提供避孕措施之前进行特定检查或测试的比例。
我们于 2019 年对提供计划生育服务的公共卫生中心和医生进行了横断面调查(n=1395)。我们估计了在为健康女性启动激素或宫内节育器(IUC)避孕之前,要求进行血压测量、盆腔检查(双合诊和宫颈检查)、巴氏涂片检查、临床乳房检查(CBE)和衣原体和淋病(CT/GC)筛查的提供者(或其卫生中心或诊所)的加权比例。我们进行了多变量回归分析,以确定与临床建议一致的盆腔检查实践相关的因素;这些建议将检查和测试分为在开始特定避孕方法之前推荐或不必要的。
总体回复率为 51%。大多数提供者在启动每种方法之前都要求进行血压测量。不必要的 CBE、巴氏涂片检查和 CT/GC 筛查在各种方法中被 14%至 33%的提供者要求。52%至 62%的提供者在放置 IUC 之前要求进行推荐的盆腔检查;然而,16%至 23%的提供者在开始非宫内激素避孕方法之前要求进行不必要的盆腔检查。与推荐的盆腔检查实践相关的因素包括有更高比例的患者使用公共资金(医疗补助或其他援助)和最近完成了正式的临床培训。
近一半(47%)的提供者在放置 IUC 之前不需要进行必要的盆腔检查。相反,许多提供者在为患者开始避孕之前要求进行不必要的检查和测试。
大多数提供者要求进行少数几项安全避孕所需的推荐检查和测试。减少不必要的检查和测试可能会减少避孕的障碍。还有机会增加推荐检查的使用,因为多达 48%的提供者在放置 IUC 之前不需要进行推荐的盆腔检查。